McGuire Capital Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,976
Closed -$275K 931
2026
Q1
$275K Buy
2,976
+1,462
+97% +$147K 0.18% 72
2025
Q4
$155K Buy
+1,514
New +$135K 0.1% 105

Other funds holding GH

McGuire Capital Advisors's GH Position: Q2 2026 in Review

McGuire Capital Advisors sold out of Guardant Health (GH) in Q2 2026, closing a stake of 2,976 shares — an estimated $275K sold.

McGuire Capital Advisors first reported a position in GH in Q4 2025 and held it in 2 quarters. The position peaked at $275K in Q1 2026. 596 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • McGuire Capital Advisors reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • McGuire Capital Advisors sold 2,976 Guardant Health shares in Q2 2026, an estimated $275K.
  • McGuire Capital Advisors first reported a position in Guardant Health in Q4 2025 and held it in 2 quarters.
  • McGuire Capital Advisors's Guardant Health position peaked at $275K in Q1 2026.
  • 596 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on McGuire Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.